Device Ffr Link Bluetooth Communication Module_ic

Ffr Link Bluetooth Communication Module

Payments companies reported to CMS as associated with Ffr Link Bluetooth Communication Module. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$603associated payments (2023-2025)
21clinicians with associated payments
1company reporting

By year

2023 $504
2024 $38.43
2025 $60.69

Payments reported as associated with Ffr Link Bluetooth Communication Module, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $290
Cardiovascular Disease $132
Internal Medicine $41.62
Adult Health (Nurse Practitioner) $17.06
Family Medicine $15.67
Registered Nurse $13.98

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ffr Link Bluetooth Communication Module

These are the largest totals companies reported as associated with Ffr Link Bluetooth Communication Module. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Bhavanadhar Penta New York, NY Interventional Cardiology $41.62
Tawseef Dar Norfolk, VA Internal Medicine $41.62
Anton Camaj New York, NY Interventional Cardiology $41.62
Chandrashekar Bohra Ocala, FL Cardiovascular Disease $41.62
Rakhee Makhija Mckinney, TX Interventional Cardiology $41.61
Yash Jobanputra Worcester, MA Cardiovascular Disease $41.61
Vishal Dhulipala Sumter, SC Interventional Cardiology $41.61
David Song New York, NY Interventional Cardiology $41.61
Frank Kalaba New York, NY $41.61
Christopher Jenkins Macon, GA Interventional Cardiology $32.99

Prescribed Ffr Link Bluetooth Communication Module?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.